A large multinational cohort study spanning three countries, alongside another randomized controlled trial, both concluded that GLP-1RAs usage was not associated with a significant increase in thyroid cancer risk [2, 5]
Some insurance plans cover specific medications
Jhuo, C
Ferber, Charles, Christina, Jessica, Gina, Morgan, Bella, and Juliana
How They Work Tirzepatide: This medication combines the actions of two incretin hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
Safety Considerations and NHS Prescribing Guidelines GLP-1 receptor agonists are generally well-tolerated, but prescribers and patients must be aware of common adverse effects and safety considerations outlined in MHRA guidance and product characteristics